The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[(1R)-1-(1-cyclopentyl-4-oxo-5H-pyrazolo[3,4-d]pyrimidin-6-yl)ethyl]-5-[(3S)-dithiolan-3-yl]pentanamide ID: ALA5267538
Chembl Id: CHEMBL5267538
Max Phase: Preclinical
Molecular Formula: C20H29N5O2S2
Molecular Weight: 435.62
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](NC(=O)CCCC[C@H]1CCSS1)c1nc2c(cnn2C2CCCC2)c(=O)[nH]1
Standard InChI: InChI=1S/C20H29N5O2S2/c1-13(22-17(26)9-5-4-8-15-10-11-28-29-15)18-23-19-16(20(27)24-18)12-21-25(19)14-6-2-3-7-14/h12-15H,2-11H2,1H3,(H,22,26)(H,23,24,27)/t13-,15+/m1/s1
Standard InChI Key: KUSDMIVMZJMIPH-HIFRSBDPSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.62Molecular Weight (Monoisotopic): 435.1763AlogP: 4.13#Rotatable Bonds: 8Polar Surface Area: 92.67Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.92CX Basic pKa: ┄CX LogP: 2.45CX LogD: 2.43Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -1.04
References 1. Nadur NF, de Azevedo LL, Caruso L, Graebin CS, Lacerda RB, Kümmerle AE.. (2021) The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure., 212 [PMID:33412421 ] [10.1016/j.ejmech.2020.113123 ]